Sofinnova Investments
Menlo Park, CA, USA · Growth → Series C+
Their stated focus (public profile)
Sofinnova is a healthcare investment firm with approximately $4.6B in AUM focused on life science investing, primarily therapeutic drugs. They invest in both private and public equity companies at late preclinical and clinical stages across the U.S. and Europe. Key therapeutic areas include oncology, respiratory, dermatology, ophthalmology, neurology, and women's health, with a mission to improve patient lives through science.
Stages: Growth → Series C+
Sectors: Life sciences, Cardiology, Cardiometabolic, Cns, Dermatology, Endocrinology, Femtech / women's health, Healthtech, Radiopharmaceuticals, Respiratory
On file: 20 companies on record
Website: sofinnova.com
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.